Medtronic Plc posted a better-than-expected quarterly profit on Tuesday, helped by strong sales of its diabetes and heart devices, sending the medical device maker’s shares up as much as 4.9 percent to a record high. Dublin-based Medtronic’s performance was in line with other device makers such as Boston Scientific Corp and Baxter International Inc that have also reported stronger-than-expected quarterly results. The largest U.S. standalone device maker’s diabetes unit that makes insulin pumps and glucose monitoring systems posted a 27 percent rise in sales, largely due to strong adoption …read more
Source:: Yahoo Finance
